Smoking and drinking in relation to oral and pharyngeal cancer.

Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract. BMJ (1998) 3.63

Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2009) 3.33

Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 3.00

Substantial contribution of extrinsic risk factors to cancer development. Nature (2015) 2.46

Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol (2009) 2.38

Light to moderate intake of alcohol, drinking patterns, and risk of cancer: results from two prospective US cohort studies. BMJ (2015) 2.33

A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers. Carcinogenesis (2009) 2.28

Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduct J (2006) 2.18

The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med (2005) 1.95

Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis (2009) 1.94

The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer (2003) 1.79

Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer (2001) 1.75

Oral cancer in Scotland: changing incidence and mortality. BMJ (1992) 1.74

Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol (2013) 1.73

Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol (2009) 1.70

MicroRNA profiling and head and neck cancer. Comp Funct Genomics (2009) 1.68

Conjoint developmental trajectories of young adult alcohol and tobacco use. J Abnorm Psychol (2005) 1.67

Meta-analysis of the relation between European and American smokeless tobacco and oral cancer. BMC Public Health (2007) 1.65

Coffee and tea intake and risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev (2010) 1.63

Electronic nicotine delivery systems ("e-cigarettes"): review of safety and smoking cessation efficacy. Otolaryngol Head Neck Surg (2014) 1.58

Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med (2009) 1.52

Cancer risk following pernicious anaemia. Br J Cancer (1989) 1.50

Disparities in oral and pharyngeal cancer incidence, mortality and survival among black and white Americans. J Am Dent Assoc (2006) 1.48

Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res (2010) 1.44

Oral health and risk for head and neck squamous cell carcinoma: the Carolina Head and Neck Cancer Study. Cancer Causes Control (2010) 1.41

Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer (2011) 1.41

Autoantibody approach for serum-based detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.35

Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Int J Cancer (2009) 1.30

Preventing and detecting oral cancer. Oral health care providers' readiness to provide health behavior counseling and oral cancer examinations. J Am Dent Assoc (2005) 1.29

Smokeless tobacco and oral cancer in South Asia: a systematic review with meta-analysis. J Cancer Epidemiol (2014) 1.26

Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration. Psychopharmacology (Berl) (2007) 1.24

Race/ethnicity and multiple cancer risk factors among individuals seeking smoking cessation treatment. Cancer Epidemiol Biomarkers Prev (2008) 1.23

Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol (2009) 1.22

Head and neck cancer: an evolving treatment paradigm. Cancer (2008) 1.21

Is the Scottish population living dangerously? Prevalence of multiple risk factors: the Scottish Health Survey 2003. BMC Public Health (2010) 1.20

Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. BMJ (1996) 1.20

Type of alcoholic beverage and risk of head and neck cancer--a pooled analysis within the INHANCE Consortium. Am J Epidemiol (2008) 1.19

Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Int J Epidemiol (2010) 1.18

Cancer mortality among workers in the German rubber industry: 1981-91. Occup Environ Med (1996) 1.18

Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer (2000) 1.14

11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer (2006) 1.14

Mitochondrial DNA copy number and risk of oral cancer: a report from Northeast India. PLoS One (2013) 1.14

Alcohol and head and neck cancer risk in a prospective study. Br J Cancer (2007) 1.13

Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. Carcinogenesis (2009) 1.13

Concern A review of the epidemiology of oral and pharyngeal carcinoma: update. Head Neck Oncol (2012) 1.12

Concern The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid. Head Neck Oncol (2012) 1.09

CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies. Carcinogenesis (2010) 1.09

Body mass index, cigarette smoking, and alcohol consumption and cancers of the oral cavity, pharynx, and larynx: modeling odds ratios in pooled case-control data. Am J Epidemiol (2010) 1.08

Pathways between socioeconomic status and modifiable risk factors among African American smokers. J Behav Med (2009) 1.08

MicroRNA binding site polymorphisms as biomarkers of cancer risk. Expert Rev Mol Diagn (2010) 1.06

Screening for high risk human papilloma virus (HR-HPV) subtypes, among Sudanese patients with oral lesions. Int J Clin Exp Med (2013) 1.06

A genotype-phenotype examination of cyclin D1 on risk and outcome of squamous cell carcinoma of the head and neck. Clin Cancer Res (2008) 1.06

Socioeconomic status, negative affect, and modifiable cancer risk factors in African-American smokers. Cancer Epidemiol Biomarkers Prev (2008) 1.04

Alcohol as a cause of cancer. Environ Health Perspect (1995) 1.03

Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma. Int J Cancer (2009) 1.02

Staging of laryngeal and hypopharyngeal cancer: value of imaging studies. Eur Radiol (2006) 1.02

Age-standardized incidence and mortality rates of oral and pharyngeal cancer in Puerto Rico and among Non-Hispanics Whites, Non-Hispanic Blacks, and Hispanics in the USA. BMC Cancer (2009) 1.02

Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res (2010) 1.02

Bupropion and nicotine patch as smoking cessation aids in alcoholics. Alcohol (2007) 1.02

Lifetime body mass index and risk of oral cavity and oropharyngeal cancer by smoking and drinking habits. Br J Cancer (2003) 1.01

Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. Int J Cancer (2014) 0.99

High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer. Br J Cancer (2011) 0.99

Smoke-free policies in drinking venues predict transitions in alcohol use disorders in a longitudinal U.S. sample. Drug Alcohol Depend (2012) 0.99

Spatiotemporal trends in oral cancer mortality and potential risks associated with heavy metal content in Taiwan soil. Int J Environ Res Public Health (2010) 0.99

Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke. Head Neck (2014) 0.98

Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium. Cancer Causes Control (2011) 0.98

Analysis of oral cancer epidemiology in the US reveals state-specific trends: implications for oral cancer prevention. BMC Public Health (2008) 0.98

Patients compliance in an early detection program for upper aero-digestive tract tumours in north-eastern Italy. Soz Praventivmed (1990) 0.98

Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am (2014) 0.97

Longitudinal evaluation of smoke-free Scotland on pub and home drinking behavior: findings from the International Tobacco Control Policy Evaluation Project. Nicotine Tob Res (2009) 0.97

Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma. Cancer (2008) 0.97

Alcohol consumption and cancers of the oral cavity and pharynx from 1988 to 2009: an update. Eur J Cancer Prev (2010) 0.97

Joint effects of alcohol consumption and polymorphisms in alcohol and oxidative stress metabolism genes on risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev (2011) 0.95

Smokeless tobacco and risk of head and neck cancer: evidence from a case-control study in New England. Int J Cancer (2012) 0.95

Cancer prevention strategies: use of cancer prevention research registries. Environ Health Perspect (1995) 0.95

Spit (smokeless) tobacco use by high school baseball athletes in California. Tob Control (2000) 0.95

An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies. Cancer Causes Control (2011) 0.94

p16INK4A and p14ARF gene promoter hypermethylation as prognostic biomarker in oral and oropharyngeal squamous cell carcinoma: a review. Dis Markers (2014) 0.94

Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 1C*1 allele, possibly due to salivary acetaldehyde. Gut (2004) 0.94

Head and neck cancer in a developing country: a population-based perspective across 8 years. Oral Oncol (2010) 0.94

The influence of alcohol consumption on worldwide trends in mortality from upper aerodigestive tract cancers in men. J Epidemiol Community Health (1996) 0.93

Neighborhood deprivation and clinical outcomes among head and neck cancer patients. Health Place (2012) 0.93

Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients. Br J Cancer (2015) 0.93

Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas. Br J Cancer (1990) 0.93

Racial differences in the relationship between tobacco, alcohol, and squamous cell carcinoma of the head and neck. Cancer Causes Control (2012) 0.92

Perineural growth in head and neck squamous cell carcinoma: a review. Oral Oncol (2014) 0.92

Prevalence and correlates of smoking on the roof of the world. Tob Control (2001) 0.92

Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium. Int J Epidemiol (2015) 0.91

Molecular mechanisms of head and neck cancer. Expert Rev Anticancer Ther (2008) 0.91

Epigenetic disregulation in oral cancer. Int J Mol Sci (2012) 0.91

Smoking and drinking in relation to oral cancer and oral epithelial dysplasia. Cancer Causes Control (2007) 0.91

Oral and pharyngeal cancer incidence and mortality among Hispanics, 1996-2002: the need for ethnoregional studies in cancer research. Am J Public Health (2006) 0.91

Salivary endothelin-1 potential for detecting oral cancer in patients with oral lichen planus or oral cancer in remission. Oral Oncol (2011) 0.90

Integrated smoking cessation and binge drinking intervention for young adults: a pilot investigation. Ann Behav Med (2010) 0.90

Hepatitis C virus infection and risk of cancer: a population-based cohort study. Clin Epidemiol (2010) 0.90

A case-control study of the association of the polymorphisms and haplotypes of DNA ligase I with lung and upper-aerodigestive-tract cancers. Int J Cancer (2008) 0.89

Cancers in Australia in 2010 attributable to the consumption of alcohol. Aust N Z J Public Health (2015) 0.89

Modifiable risk behaviors in patients with head and neck cancer. Cancer (2013) 0.89

Oral and pharyngeal cancer in South Asians and non-South Asians in relation to socioeconomic deprivation in South East England. Br J Cancer (2008) 0.89

Dairy products, leanness, and head and neck squamous cell carcinoma. Head Neck (2008) 0.89

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68

The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology (1998) 12.32

Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17

Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57

Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54

A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09

The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81

Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68

Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62

Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59

Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA (1994) 4.35

Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33

Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09

Selection of controls in case-control studies. I. Principles. Am J Epidemiol (1992) 3.94

Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol (1992) 3.80

Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72

Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res (2001) 3.70

Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol (1997) 3.66

Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63

Population declines in North American birds that migrate to the neotropics. Proc Natl Acad Sci U S A (1989) 3.58

Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36

Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34

Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30

Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28

Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26

High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood (1996) 3.24

An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22

Patterns of tuberculosis transmission in Central Los Angeles. JAMA (1997) 3.21

Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer (1991) 3.14

A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13

Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet (1977) 3.05

Childhood leukemia and parents' occupational and home exposures. J Natl Cancer Inst (1987) 3.03

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00

Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98

Epidemiology and prevention of breast cancer. Annu Rev Public Health (1996) 2.94

A randomised controlled trial of hospice care. Lancet (1984) 2.93

A carcinogenic potency database of the standardized results of animal bioassays. Environ Health Perspect (1984) 2.92

Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res (1988) 2.90

Selection of controls in case-control studies. III. Design options. Am J Epidemiol (1992) 2.88

Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst (1995) 2.83

Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83

Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78

Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76

Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet (1998) 2.74

Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71

The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68

The descriptive epidemiology of craniopharyngioma. J Neurosurg (1998) 2.66

Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66

Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65

The changing epidemiology of esophageal cancer. Semin Oncol (1999) 2.65

A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. JAMA (1993) 2.62

A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59

Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55

Growth and decay of pulmonary function in healthy blacks and whites. Respir Physiol (1978) 2.55

Lung cancer in nonsmoking women: a multicenter case-control study. Cancer Epidemiol Biomarkers Prev (1993) 2.53

Aminophylline therapy for acute bronchospastic disease in the emergency room. Ann Intern Med (1991) 2.51

Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50

International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50

Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract (2006) 2.49

Reliability of surrogate information on cigarette smoking by type of informant. Am J Epidemiol (1987) 2.49

Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49

Mathematical modeling strategies for the analysis of epidemiologic research. Annu Rev Public Health (1985) 2.48

Geographic patterns of lung cancer: industrial correlations. Am J Epidemiol (1976) 2.45

Transmission of tuberculosis among the urban homeless. JAMA (1996) 2.45

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43

Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43

Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer (1992) 2.40

Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst (1995) 2.36

Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev (2002) 2.36

Coronal caries in the primary and permanent dentition of children and adolescents 1-17 years of age: United States, 1988-1991. J Dent Res (1996) 2.36

Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med (1992) 2.34

Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst (2000) 2.32

A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control (2001) 2.31

Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol (2001) 2.30

Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst (1969) 2.30